These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 16798061

  • 1. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, Freire AR.
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, Olasz L.
    Anticancer Res; 2006 Feb; 26(2B):1557-62. PubMed ID: 16619571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 6. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.
    Radiother Oncol; 2006 Mar 15; 78(3):270-5. PubMed ID: 16564589
    [Abstract] [Full Text] [Related]

  • 7. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
    Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI.
    Head Neck; 2002 Aug 15; 24(8):737-47. PubMed ID: 12203798
    [Abstract] [Full Text] [Related]

  • 8. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May 15; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL, Bereuter J.
    J Otolaryngol; 2000 Feb 15; 29(1):28-34. PubMed ID: 10709169
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
    Moral Nakamura D, da Graça Pinto H, Baena Elchin C, Thomazotti Berard L, Abreu Alves F, Azeredo Alves Antunes L, Pena Coto N.
    Radiother Oncol; 2023 Sep 15; 186():109715. PubMed ID: 37207874
    [Abstract] [Full Text] [Related]

  • 11. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients.
    Jaguar GC, Lima EN, Kowalski LP, Pellizzon AC, Carvalho AL, Boccaletti KW, Alves FA.
    Radiother Oncol; 2015 May 15; 115(2):253-6. PubMed ID: 25890572
    [Abstract] [Full Text] [Related]

  • 12. Radiotherapy-induced salivary dysfunction.
    Ship JA, Hu K.
    Semin Oncol; 2004 Dec 15; 31(6 Suppl 18):29-36. PubMed ID: 15726520
    [Abstract] [Full Text] [Related]

  • 13. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):981-91. PubMed ID: 17145528
    [Abstract] [Full Text] [Related]

  • 14. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R.
    Expert Rev Anticancer Ther; 2011 Sep 15; 11(9):1437-48. PubMed ID: 21929317
    [Abstract] [Full Text] [Related]

  • 15. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
    Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard CH.
    Radiat Oncol; 2007 Jan 05; 2():3. PubMed ID: 17207274
    [Abstract] [Full Text] [Related]

  • 16. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL, Chao KS, Haughey B.
    Semin Oncol; 2004 Dec 05; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [Abstract] [Full Text] [Related]

  • 17. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.
    Lin SC, Jen YM, Chang YC, Lin CC.
    J Pain Symptom Manage; 2008 Aug 05; 36(2):141-8. PubMed ID: 18395402
    [Abstract] [Full Text] [Related]

  • 18. Preventing radiation induced xerostomia.
    Koukourakis MI, Danielidis V.
    Cancer Treat Rev; 2005 Nov 05; 31(7):546-54. PubMed ID: 16257125
    [Abstract] [Full Text] [Related]

  • 19. Laser phototherapy as topical prophylaxis against radiation-induced xerostomia.
    Simões A, de Campos L, de Souza DN, de Matos JA, Freitas PM, Nicolau J.
    Photomed Laser Surg; 2010 Jun 05; 28(3):357-63. PubMed ID: 19814701
    [Abstract] [Full Text] [Related]

  • 20. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
    Jen YM, Lin YC, Wang YB, Wu DM.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar 05; 101(3):322-7. PubMed ID: 16504865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.